Stockreport

Landmark Study Demonstrates Sustained Clinical Benefits of Flexitouch® Plus as First-Line Therapy in Treating Head and Neck Cancer-Related Lymphedema

Tactile Systems Technology, Inc.  (TCMD) 
Last tactile systems technology, inc. earnings: 2/26 04:05 pm Check Earnings Report
US:NASDAQ Investor Relations: investors.tactilemedical.com/investors
PDF MINNEAPOLIS, Oct. 28, 2025 (GLOBE NEWSWIRE) -- Tactile Systems Technology, Inc. (“Tactile Medical”; the “Company”) (Nasdaq: TCMD), a medical technology company providi [Read more]